| Date |
Event |
Presentation |
Speakers |
|
September 4, 2016
|
10th Vaccine Congress
|
OPENING PLENARY SESSION: Vaccinology in the 21st century
|
Gregory A. Poland
|
|
|
|
Opening remarks by Conference
|
Gregory A. Poland
|
|
|
|
Workshop: Publish or Perish
|
Gregory A. Poland
|
|
March 2, 2014
|
Alzheimer’s Disease – From Fundamental Insights to Light at the End of the Translational Tunnel (Q8)
|
Phenotypic and Genotypic Complexity of AD and PD (Joint) Registered attendees can view abstracts starting on 02/02/2014
|
Dennis Dickson
|
|
July 21, 2013
|
54th Annual Short Course on Medical and Experimental Mammalian Genetics
|
Thur sday, July 25 Pharmacogenomics: Development, Science and Translation
|
Richard M. Weinshilboum
|
|
May 31, 2013
|
ASCO Annual Meeting 2013
|
What's New and Improved in the Care of Children with Rhabdomyosarcoma?
|
Carola A. S. Arndt
|
|
|
|
Responding to Common Concerns of Patients with Cancer: What's New—In a Nutshell—From Research to Therapeutic Strategies
|
Charles L. Loprinzi
|
|
|
|
Uncommon Lymphoproliferative Disorders (C01)
|
Angela Dispenzieri
|
|
|
|
Rationally Combining Targeted and Pathway-Specific Agents
|
Edith A Perez
|
|
|
|
Special Session
|
David P Steensma
|
|
|
|
Education Sessions
|
Gloria M. Petersen
|
|
April 6, 2013
|
AACR Annual Meetings
|
Targeting Lymphoid Malignancies: Working from the Outside In Co-Chairpersons: John P. Leonard, Weill Cornell Medical Center, New York, NY, and John C. Byrd, The Ohio State University Comprehensive Cancer Center, Columbus, OH
|
James R. Cerhan
|
|
|
|
Endocrine Resistance in Breast Cancer Chairperson: Nancy E. Davidson, University of Pittsburgh Cancer Institute, Pittsburgh, PA
|
Matthew P . Goetz
|
|
|
|
DNA Damage Response: What Do We Know Now and What Will We Learn Next? Chairperson: Junjie Chen, The University of Texas MD Anderson Cancer Center, Houston, TX
|
Junjie Chen
|
|
|
|
Genetic Epidemiology of Pancreatic Cancer Gloria M. Petersen, Mayo Clinic College of Medicine, Rochester, MN
|
Gloria M. Petersen
|
|
January 31, 2013
|
5th Immunotherapeutics & Immunomonitoring
|
The Immune System in Breast Cancer Initiation and Progression: Role of Epithelial to Mesenchymal Transition
|
Keith Knutson
|
|
December 4, 2012
|
CTRC-AACR San Antonio Breast Cancer Symposium
|
Mini-Symposium 2 - Exhibit Hall D Breast Density: Mechanisms and Clinical Implications
|
Celine M. Vachon
|
|
December 9, 2011
|
44th Annual New York Cardiovascular Symposium: Major Topics in Cardiology Today
|
Introductions
|
David R. Holmes
|
|
July 28, 2011
|
International Conference on Biomedical Ontology
|
A Case Study of ICD-11 Anatomy Value Set Extraction from SNOMED CT
|
Harold Solbrig
|
|
|
|
Ontology and the Electronic Health Record
|
Christopher G. Chute
|
|
|
|
Panel | Problems with Existing EHR Paradigms and How Ontology Can Solve Them
|
Christopher G. Chute
|
|
February 17, 2011
|
15th Annual International Congress on Hematologic Malignancies: Focus on Leukemias, Lymphomas, and Myeloma
|
Promising New Drugs in Clinical Trials in Myeloma
|
Keith Stewart
|
|
|
|
CON
|
Keith Stewart
|
|
|
|
How I Treat Myelofibrosis If No Clinical Trial Is Available
|
Ruben A Mesa
|
|
|
|
Multiple Myeloma
|
Keith Stewart
|
|
|
|
Chronic Myeloid Leukemia | Myeloproliferative Neoplasms
|
Ruben A Mesa
|
|
January 12, 2011
|
Type 2 Diabetes, Insulin Resistance and Metabolic Dysfunction (J1)
|
Insulin Resistance, Mitochondrial Dysfunction and Lipotoxicity in Humans | Muscle Mitochondrial Dysfunction and Muscle Insulin Resistance in Diabetes
|
Sreekumaran Nair
|
|
January 12, 2011
|
Obesity (J2)
|
Diabetes (J1) | Muscle Mitochondrial Dysfunction and Muscle Insulin Resistance in Diabetes
|
Sreekumaran Nair
|
|
September 21, 2009
|
Third Annual Exploring Next Generation Sequencing
|
Genome Complexity Reduction and Next-Generation DNA Sequencing in a Clinical Diagnostics Environment
|
Matthew Ferber
|
|
May 30, 2008
|
ASCO Annual'08 Meeting
|
breast cancer-- Developmental Therapeutic Approaches to Triple-Negative Breast Cancer
|
Edith A Perez
|
|
|
|
developmental therapeutics-- Developmental Therapeutic Approaches to Triple-Negative Breast Cancer
|
Edith A Perez
|
|
|
|
gastrointestinal (noncolorectal) cancer-- Multimodality Treatment of Bile Duct Tumors (M14)
|
Steven R. Alberts
|
|
|
|
leukemia, myelodysplasia, and transplantation-- Myeloproliferative Disorders at the Cutting Edge
|
Ayalew Tefferi
|
|
|
|
lymphoma and plasma cell disorders-- Initial Therapy for Multiple Myeloma: Considerations for an Integrated Risk- Adapted Approach
|
S. Vincent Rajkumar
|
|
|
|
meet the professor sessions-- Multimodality Treatment of Bile Duct Tumors (M14)
|
Steven R. Alberts
|
|
February 17, 2008
|
GRC - Glycolipid & Sphingolipid Biology
|
Inhibition of caveolar endocytosis, microdomain formation and integrin signaling by a non-natural glycosphingolipid analog
|
Ramandeep Singh Takhter
|
|
December 1, 2007
|
47TH American Socieity of Cell Biology
|
Symposium II:Architecture of Signaling Systems
|
Marks L Richard
|
|
|
|
Stochasticity and Cell Fate
|
Marks L Richard
|
|
|
|
Advances in Bone Cell Molecular Biology: Epigenetic Control
|
Jennifer Westendorf
|
|
|
|
Dynamics of Rafts, Stabilized Rafts, and Other Non-Raft Domains of
|
Mark A McNiven
|
|
September 7, 2007
|
The 2007 Breast Symposium
|
General Session VI: HER2 Positive Breast Cancer 10:00 AM — 11:45 AM
|
Edith A Perez
|
How We Rank